Physician profile
Xihui Lin
NPI 1871868190
$4,111.54
in general payments reported to CMS, 2019-2025
20 companies · $646 in 2025
The $646 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $843 · 2020: $148 · 2021: $229 · 2022: $1,837 · 2023: $131 · 2024: $277 · 2025: $646.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,055.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,054.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alimera Sciences, INC. | $1,565.31 | 2022 | |
| Allergan, INC. | $700.36 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $604.09 | 2019-2025 | Eylea Hd, Eylea |
| Apellis Pharmaceuticals, INC. | $161.44 | 2022-2024 | Syfovre |
| Abbvie INC. | $160.32 | 2022-2025 | |
| Ani Pharmaceuticals, INC. | $138.73 | 2022-2025 | Purified Cortrophin Gel, Yutiq |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $136.70 | 2020-2021 | |
| Mallinckrodt Enterprises LLC | $112.29 | 2019 | |
| Novartis Pharmaceuticals Corporation | $101.30 | 2019-2020 | |
| Bausch & Lomb Americas INC. | $71.63 | 2022-2025 | Stellaris |
| Alcon Vision LLC | $63.71 | 2019-2022 | |
| Mallinckrodt Hospital Products INC. | $44.73 | 2020-2022 | |
| Biotissue Holdings INC. | $44.55 | 2025 | |
| Harrow Eye, LLC | $39.67 | 2025 | Iheezo |
| Genentech USA, INC. | $38.32 | 2023-2025 | Vabysmo, Susvimo |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dompe US, INC. | $37.60 | 2025 | Oxervate |
| Sandoz INC. | $30.62 | 2025 | Cimerli |
| Tarsus Pharmaceuticals, INC. | $23.74 | 2025 | Xdemvy |
| Astellas Pharma US INC | $22.94 | 2024 | Izervay |
| Beaver-Visitec International, INC. | $13.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Xihui Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.